Summary
The adverse consequences of growth hormone (GH) deficiency (GHD) on bone growth in children is well described. Whether adult GHD is associated with bone loss is unknown. We evaluated 14 patients with hypothalamicpituitary tumors (HPT) acquired during adulthood (5 men, 9 women; \(\bar x\) age=48.1±4.6 years; \(\bar x\) BMI=28.8±1.7) and 14 age-, sex-, and weight-matched controls. Nine HPT patients were receiving gonadal steroid replacement therapy for a mean of 11 years. All subjects had basal IGF-I and IGFBP-3 levels prior to testing with GH-releasing hormone [1 μg/kg IV bolus; responses expressed as maximum percentage increase above baseline (PERGH)]. Bone mineral density (BMD) of the spine, hip, and total body were measured by dual-energy X-ray absorptiometry. Mean BMD Z-scores of the HPT patients were significantly lower in the femoral neck, Ward's triangle, and trochanter than in controls (all P<0.05). Mean total body BMD (g/cm2) was also lower in the patient group (1.04±0.03 versus 1.13±0.03, P<0.05). For the subgroup of HPT patients receiving conventional gonadal steroids, mean BMD Z-scores of the lumbar spine also were significantly lower than controls (-1.84±0.43 versus -0.57±0.46, P<0.05). PERGH and IGF-l were correlated with Z-scores of the femoral neck (r=0.47, P<0.01; r=0.45, P<0.01) and Ward's triangle (r=0.47, P<0.01; r=0.41, P<0.05). These results indicate that adults with previous HPTs have significantly lower spine and hip BMD compared with healthy controls, regardless of gonadal steroid therapy, and that this premature bone loss is associated with relative GHD. IGF-I and PERGH measurements might be useful markers to identify such patients at risk for reduced BMD.
Similar content being viewed by others
References
Heany RP, Harris WH, Cockin J, Weinberg EH (1972) Growth hormone: the effect on skeletal renewal in the adult dog: II. Mineral kinetic studies. Calcif Tissue Res 10:14–22
Thorngren KG, Hansson LI, Menander-Sellman K, Stenstrom A (1973) Effect of dose and administration period of growth hormone on longitudinal bone growth in the hypophysectomized rat. Acta Endocrinol (Copenh) 74:1–23
Rudman D, Feller AG, Nagraj HS, et al. (1990) Effects of growth hormone in men over 60 years old. N Engl J Med 323:1–6
Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A (1990) A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Miner Res 5:609–618
Stracke H, Schulz A, Moeller D, Rossol S, Schatz H (1984) Effect of growth hormone on osteoblasts and demonstration of somatomedin-C/IGF I in bone organ culture. Acta Endocrinol 107:16–24
Ernst M, Rodan GA (1990) Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127:807–814
Blum WF, Ranke MB (1990) Use of insulin-like growth factor-binding protein 3 for the evaluation of growth disorders. Horm Res 33:(suppl 4):31–37
Jorgensen JO, Blum WF, Moller N, Ranke MB, Christiansen JS (1990) Circadian patterns of serum insulin-like growth factor (IGF) II and IGF binding protein 3 in growth hormone-deficient patients and age-and sex-matched normal subjects. Acta Endocrinol (Copenh) 123:257–262
Rico H, Del Rio A, Vila T, Patino R, Carrera F, Espinos D (1979) The role of growth hormone in the pathogenesis of postmenopausal osteoporosis. Arch Intern Med 139:1263–1265
Smith RW (1967) Dietary and hormonal factors in bone loss. Fed Proc 26:1737–1746
Dequeker J, Burssens A, Bouillon R (1982) Dynamics of growth hormone secretion in patients with osteoporosis and in patients with osteoarthrosis. Horm Res 16:353–356
Shore RM, Mazess RB, Bargman GJ (1980) Bone mineral status in growth hormone deficiency. J Pediatr 96:393–396
Degerblad M, Almkvist O, Grunditz R, et al. (1990) Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol (Copenh) 123:185–193
Ferrandez A, Zachmann M, Prader A, Illig R (1970) Isolated growth hormone deficiency in prepubertal children. Influence of human growth hormone on longitudinal growth, adipose tissue, bone mass and bone maturation. Helv Paediatr Acta 6:566–576
Kaufman J-M, Taelman P, Vermeulen A, Vandeweghe M (1992) Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 74:118–123
Adlard P, Davies PS, Sobnack R, Britton K, Preece MA (1989) Body fat and bone density in growth hormone deficient adults (abstract). Horm Res 31 (suppl 1):35
Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP (1981) Impaired growth hormone secretion in the adult population. Relation to age and adiposity. J Clin Invest 67:1361–1369
Lang I, Schernthaner G, Pietschmann P, Kurz R, Stephenson JM, Templ H (1987) Effects of sex and age on growth hormone responses to growth hormone-releasing hormone in healthy individuals. J Clin Endocrinol Metab 65:535–540
Ghigo E, Corrias A, Imperiale E, et al. (1989) Effect of cholinergic enhancement by pyridostigmine on growth hormone secretion in obese adults and children. Metabolism 38:631–633
Daughaday WH, Kapadia M, Mariz I (1987) Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay. J Lab Clin Med 109:355–363
Greenspan SL, Oppenheim DS, Klibanski A (1989) Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 110:526–531
Parfitt AM (1990) Interpretation of bone densitometry measurements: disadvantages of a percentage scale and a discussion of some alternatives. J Bone Miner Res 5:537–540
Finkelstein JS, Klibanski A, Neer RM, et al. (1989) Increases in bone density during treatment of men with idiopathic hypogonadotropic J Clin endocrinol Metab 69:776–783
Esteban NV, Loughlin T, Yergey AL, et al. (1991) Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 71:39–45
Wuster C, Blum W, Schlemilch S, Ranke MB, Ziegler R (1991) Decreased serum levels of IGF-binding protein (IGFBP-3) in osteoporosis (abstract). J Bone Miner Res 6(suppl 1):S107
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bing-You, R.G., Denis, MC. & Rosen, C.J. Low bone mineral density in adults with previous hypothalamic-pituitary tumors: Correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3. Calcif Tissue Int 52, 183–187 (1993). https://doi.org/10.1007/BF00298715
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00298715